ATE209191T1 - Parazinon thrombin inhibitoren - Google Patents
Parazinon thrombin inhibitorenInfo
- Publication number
- ATE209191T1 ATE209191T1 AT97918780T AT97918780T ATE209191T1 AT E209191 T1 ATE209191 T1 AT E209191T1 AT 97918780 T AT97918780 T AT 97918780T AT 97918780 T AT97918780 T AT 97918780T AT E209191 T1 ATE209191 T1 AT E209191T1
- Authority
- AT
- Austria
- Prior art keywords
- parazinone
- thrombin inhibitors
- thrombin
- inhibitors
- compounds
- Prior art date
Links
- 229940122388 Thrombin inhibitor Drugs 0.000 title 1
- 239000003868 thrombin inhibitor Substances 0.000 title 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1604196P | 1996-04-23 | 1996-04-23 | |
| GBGB9609714.2A GB9609714D0 (en) | 1996-05-09 | 1996-05-09 | Pyridinone thrombin inhibitors |
| US4300997P | 1997-04-14 | 1997-04-14 | |
| PCT/US1997/006744 WO1997040024A1 (en) | 1996-04-23 | 1997-04-18 | Pyrazinone thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209191T1 true ATE209191T1 (de) | 2001-12-15 |
Family
ID=27268274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97918780T ATE209191T1 (de) | 1996-04-23 | 1997-04-18 | Parazinon thrombin inhibitoren |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0900207B1 (de) |
| JP (1) | JP3140790B2 (de) |
| KR (1) | KR20000010650A (de) |
| AT (1) | ATE209191T1 (de) |
| AU (1) | AU714985B2 (de) |
| BG (1) | BG102948A (de) |
| BR (1) | BR9708859A (de) |
| CA (1) | CA2252964A1 (de) |
| CZ (1) | CZ340898A3 (de) |
| DE (1) | DE69709727T2 (de) |
| EE (1) | EE9800353A (de) |
| HR (1) | HRP970211A2 (de) |
| IL (1) | IL126404A0 (de) |
| IS (1) | IS4853A (de) |
| NO (1) | NO984928L (de) |
| NZ (1) | NZ331993A (de) |
| PE (1) | PE13399A1 (de) |
| PL (1) | PL329441A1 (de) |
| SK (1) | SK145398A3 (de) |
| TR (1) | TR199802133T2 (de) |
| WO (1) | WO1997040024A1 (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU746024B2 (en) * | 1996-04-23 | 2002-04-11 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| AU4270297A (en) | 1996-09-16 | 1998-04-02 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
| AU728006B2 (en) * | 1997-03-24 | 2001-01-04 | Merck & Co., Inc. | Thrombin inhibitors |
| US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| CA2329914A1 (en) * | 1998-05-19 | 1999-11-25 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| EP1082324A4 (de) * | 1998-05-26 | 2002-01-02 | Merck & Co Inc | Imidazopyridinverbindungen als thrombininhibitoren |
| NZ508669A (en) | 1998-06-11 | 2003-06-30 | Dimensional Pharm Inc | Pyrazinone protease inhibitors |
| DE69912379T2 (de) * | 1998-08-14 | 2004-05-06 | Pfizer Inc. | Antithrombosemittel |
| CA2343109A1 (en) * | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | Thrombin inhibitors |
| WO2000026210A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| AU747776B2 (en) | 1998-10-30 | 2002-05-23 | Merck & Co., Inc. | Thrombin inhibitors |
| WO2000038683A1 (en) | 1998-12-23 | 2000-07-06 | Du Pont Pharmaceuticals Company | THROMBIN OR FACTOR Xa INHIBITORS |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| HUP0202191A3 (en) * | 1999-05-19 | 2003-02-28 | Pharmacia Corp Chicago | Substituted polycyclic aryl and heteroaryl pirazinones useful for selective inhibition of the coagulation cascade and pharmaceutical compositions containing them |
| US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| EP1586565A1 (de) * | 1999-05-19 | 2005-10-19 | Pharmacia Corporation | Substituierte polycyclische aryl und heteroarylpyrazinone zur selektiven Hemmung von der Blutgerinnungskaskade |
| US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| UA58636C2 (uk) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| ATE344249T1 (de) * | 1999-07-19 | 2006-11-15 | Merck Frosst Canada Ltd | Pyrazinone, diese verbindungen enthaltende zusammenstellungen |
| EP1259506A1 (de) | 1999-11-23 | 2002-11-27 | Merck & Co., Inc. | Pyrazinone thrombin inhibitoren |
| WO2001068605A1 (en) | 2000-03-13 | 2001-09-20 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| EP1267876A1 (de) | 2000-03-23 | 2003-01-02 | Merck & Co., Inc. | Thrombinhemmer |
| ATE289299T1 (de) | 2000-04-05 | 2005-03-15 | Pharmacia Corp | Polyzyclisch aryl und heteroaryl substituierte 4- pyronen verwendbar als selektive hemmung von dem koagulationsprozess |
| AU2001251315A1 (en) | 2000-04-05 | 2001-10-23 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| WO2001079193A2 (en) * | 2000-04-14 | 2001-10-25 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| US6506760B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| US6506761B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| EP1274676A2 (de) | 2000-04-17 | 2003-01-15 | Pharmacia Corporation | Polycyclische aryl- und heteroaryl- substuierte 1,4-chinone zur selektiven hemmung des blutgerinnungsprozesses |
| MXPA03000512A (es) | 2000-07-17 | 2003-10-06 | Dimensional Pharm Inc | Oxiguanidina-pirazinonas ciclicas como inhibidores de proteasas. |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| CA2430037A1 (en) | 2000-11-20 | 2002-05-30 | Michael S. South | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| BR0213092A (pt) | 2001-10-03 | 2004-10-19 | Pharmacia Corp | Compostos heterocìclicos de 6 elementos úteis para a inibição seletiva da cascata de coagulação |
| MXPA04003170A (es) | 2001-10-03 | 2004-07-08 | Pharmacia Corp | Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion. |
| AP1822A (en) | 2002-02-14 | 2008-01-30 | Pharmacia Corp | Substituted pyridinones as modulators of P38 MAP kinase. |
| GB0306615D0 (en) * | 2003-03-22 | 2003-04-30 | Astrazeneca Ab | New use |
| EP1526131A1 (de) * | 2003-10-22 | 2005-04-27 | Graffinity Pharmaceuticals Aktiengesellschaft | Aminoalkyl-Pyrazinone und -Pyridone verwendbar als Thrombininhibitoren |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| BRPI0612045A2 (pt) * | 2005-06-17 | 2018-07-24 | Astrazeneca Ab | composto, formulação farmacêutica, uso de um composto, método de tratamento de uma condição, e, processo para preparação de um composto |
| CN108271369A (zh) | 2015-10-23 | 2018-07-10 | 法尔玛赞公司 | 用于制备色胺及其衍生物的新工艺 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2037738T3 (es) * | 1986-09-26 | 1993-07-01 | Ciba-Geigy Ag | Procedimiento para la obtencion de aminopirazinonas y aminotriazinonas. |
-
1997
- 1997-04-18 PL PL97329441A patent/PL329441A1/xx unknown
- 1997-04-18 WO PCT/US1997/006744 patent/WO1997040024A1/en not_active Ceased
- 1997-04-18 CA CA002252964A patent/CA2252964A1/en not_active Abandoned
- 1997-04-18 SK SK1453-98A patent/SK145398A3/sk unknown
- 1997-04-18 KR KR1019980708609A patent/KR20000010650A/ko not_active Withdrawn
- 1997-04-18 DE DE69709727T patent/DE69709727T2/de not_active Expired - Fee Related
- 1997-04-18 EP EP97918780A patent/EP0900207B1/de not_active Expired - Lifetime
- 1997-04-18 JP JP09538296A patent/JP3140790B2/ja not_active Expired - Fee Related
- 1997-04-18 EE EE9800353A patent/EE9800353A/xx unknown
- 1997-04-18 TR TR1998/02133T patent/TR199802133T2/xx unknown
- 1997-04-18 AU AU26799/97A patent/AU714985B2/en not_active Ceased
- 1997-04-18 IL IL12640497A patent/IL126404A0/xx unknown
- 1997-04-18 AT AT97918780T patent/ATE209191T1/de active
- 1997-04-18 BR BR9708859A patent/BR9708859A/pt not_active Application Discontinuation
- 1997-04-18 NZ NZ331993A patent/NZ331993A/xx unknown
- 1997-04-18 CZ CZ983408A patent/CZ340898A3/cs unknown
- 1997-04-21 HR HR60/043,009A patent/HRP970211A2/xx not_active Application Discontinuation
- 1997-04-23 PE PE1997000308A patent/PE13399A1/es not_active Application Discontinuation
-
1998
- 1998-09-25 IS IS4853A patent/IS4853A/is unknown
- 1998-10-22 NO NO984928A patent/NO984928L/no unknown
- 1998-11-23 BG BG102948A patent/BG102948A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997040024A1 (en) | 1997-10-30 |
| TR199802133T2 (xx) | 2000-09-21 |
| CA2252964A1 (en) | 1997-10-30 |
| PL329441A1 (en) | 1999-03-29 |
| HRP970211A2 (en) | 1998-06-30 |
| CZ340898A3 (cs) | 1999-02-17 |
| EP0900207A1 (de) | 1999-03-10 |
| PE13399A1 (es) | 1999-02-11 |
| BR9708859A (pt) | 1999-08-03 |
| JP2000508334A (ja) | 2000-07-04 |
| NO984928D0 (no) | 1998-10-22 |
| EP0900207B1 (de) | 2001-11-21 |
| EE9800353A (et) | 1999-04-15 |
| SK145398A3 (en) | 1999-05-07 |
| NO984928L (no) | 1998-12-22 |
| KR20000010650A (ko) | 2000-02-25 |
| IS4853A (is) | 1998-09-25 |
| DE69709727D1 (de) | 2002-02-21 |
| IL126404A0 (en) | 1999-05-09 |
| AU714985B2 (en) | 2000-01-13 |
| JP3140790B2 (ja) | 2001-03-05 |
| NZ331993A (en) | 2000-04-28 |
| AU2679997A (en) | 1997-11-12 |
| BG102948A (bg) | 1999-11-30 |
| DE69709727T2 (de) | 2002-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69709727D1 (de) | Parazinon thrombin inhibitoren | |
| AU688952B2 (en) | Thrombin inhibitors | |
| ATE234091T1 (de) | Thrombin inhibitoren | |
| ATE214928T1 (de) | Thrombininhibitoren | |
| MA24298A1 (fr) | Inhibiteurs de protease. | |
| ATE287402T1 (de) | Nanomolare, non-peptidische inhibitoren von cathepsin d | |
| TR199800773T2 (xx) | Trombin inhibit�rleri. | |
| FI973282A7 (fi) | Trombiinin inhibiittoreita | |
| ID18142A (id) | Inhibitor metaloprotease 1,4-heterosiklik | |
| ID18141A (id) | Inhibitor metaloprotease 1,3-diheterosiklik | |
| TR199900310T2 (xx) | Trombin inhibit�rleri | |
| ID16104A (id) | Inhibitor-inhibitor serin protease. | |
| WO2003011222A3 (en) | Thrombin inhibitors | |
| DE69625230D1 (de) | Thrombininhibitoren | |
| BR9610075A (pt) | Inibidores prolil endopeptidase | |
| ZA974779B (en) | Thrombin inhibitors. | |
| ZA977209B (en) | Thrombin inhibitors. | |
| ATE227571T1 (de) | Thrombin inhibitoren | |
| ZA961276B (en) | Novel thrombin inhibitors. | |
| ZA968968B (en) | Selective thrombin inhibitors. | |
| ITMI930102A0 (it) | Inibitori della trombina | |
| GB9809784D0 (en) | Thrombin Inhibitors |